Express Scripts Holding Given New $83.00 Price Target at Credit Suisse (ESRX)
Stock analysts at Credit Suisse increased their price target on shares of Express Scripts Holding (NASDAQ:ESRX) from $75.00 to $83.00 in a report issued on Friday, AnalystRatingsNetwork reports. Credit Suisse’s price objective points to a potential upside of 13.85% from the company’s current price.
Shares of Express Scripts Holding (NASDAQ:ESRX) traded up 0.79% during mid-day trading on Friday, hitting $73.4775. 3,891,268 shares of the company’s stock traded hands. Express Scripts Holding has a 52-week low of $53.05 and a 52-week high of $74.21. The stock has a 50-day moving average of $69.23 and a 200-day moving average of $65.50. The company has a market cap of $59.209 billion and a price-to-earnings ratio of 32.78.
Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings results on Friday, October 25th. The company reported $1.08 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.08. The company had revenue of $25.92 billion for the quarter, compared to the consensus estimate of $25.01 billion. During the same quarter last year, the company posted $1.02 earnings per share. Express Scripts Holding’s revenue was down 3.2% compared to the same quarter last year. On average, analysts predict that Express Scripts Holding will post $4.32 earnings per share for the current fiscal year.
In other Express Scripts Holding news, Director Nicholas Lahowchic sold 7,650 shares of the stock in a transaction that occurred on Thursday, January 9th. The shares were sold at an average price of $72.00, for a total value of $550,800.00. Following the sale, the director now directly owns 24,903 shares in the company, valued at approximately $1,793,016. The sale was disclosed in a legal filing with the SEC, which is available at this link.
ESRX has been the subject of a number of other recent research reports. Analysts at Mizuho raised their price target on shares of Express Scripts Holding from $74.00 to $86.00 in a research note to investors on Friday. They now have a “buy” rating on the stock. Separately, analysts at Jefferson Research downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note to investors on Friday, January 3rd. Finally, analysts at Goldman Sachs Group Inc. raised their price target on shares of Express Scripts Holding from $75.00 to $77.00 in a research note to investors on Tuesday, December 17th. Seven analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company’s stock. Express Scripts Holding has a consensus rating of “Buy” and an average target price of $72.24.
Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.